Noevir Holdings Co Ltd
TSE:4928
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Noevir Holdings Co Ltd
Free Cash Flow
Noevir Holdings Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Noevir Holdings Co Ltd
TSE:4928
|
Free Cash Flow
¥5.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Free Cash Flow
¥65.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Free Cash Flow
¥30.6B
|
CAGR 3-Years
26%
|
CAGR 5-Years
23%
|
CAGR 10-Years
11%
|
|
|
Kao Corp
TSE:4452
|
Free Cash Flow
¥128.8B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
2%
|
|
|
F
|
Fancl Corp
TSE:4921
|
Free Cash Flow
¥10.1B
|
CAGR 3-Years
29%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Free Cash Flow
¥11.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
0%
|
|
Noevir Holdings Co Ltd
Glance View
In the versatile world of beauty and wellness, Noevir Holdings Co Ltd. stands as a testament to astute innovation combined with a well-honed business acumen. Founded in Japan, this company has expertly navigated the delicate balance of tradition and modernity to emerge as a prominent figure in the skincare and cosmetic industries. Noevir's strategy is rooted in the meticulous formulation of its products, drawing inspiration from natural ingredients, which reflects the company’s keen attention to quality and detail. By leveraging advanced research and development techniques, Noevir crafts a diverse range of skincare and personal care products designed to cater to the discerning needs of its clientele. They operate primarily through direct sales channels, allowing them to maintain a personal relationship with their customers, understanding their preferences deeply and ensuring a consistent brand experience. Financially, Noevir Holdings generates revenue by employing a multi-faceted business model, anchoring itself in both domestic and international markets. Besides its leading role in the cosmetics sector, the company diversifies through its involvement in pharmaceuticals and health foods, broadening its portfolio to mitigate market risks. This diversity not only stabilizes the company’s revenue streams but also aligns with the increasing consumer emphasis on holistic health and wellness solutions. Noevir's ability to anticipate and respond to market trends ensures its growth trajectory, having firmly established its brand in the Asian market while progressively expanding its footprint across regions. As a result, the company's strategy encompasses not just product innovation but also a robust marketing and distribution network that reinforces its position as a leader in the beauty and wellness industry.
See Also
What is Noevir Holdings Co Ltd's Free Cash Flow?
Free Cash Flow
5.4B
JPY
Based on the financial report for Dec 31, 2025, Noevir Holdings Co Ltd's Free Cash Flow amounts to 5.4B JPY.
What is Noevir Holdings Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
6%
Over the last year, the Free Cash Flow growth was -12%. The average annual Free Cash Flow growth rates for Noevir Holdings Co Ltd have been 2% over the past three years , -1% over the past five years , and 6% over the past ten years .